- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...
- Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief ...
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its sale ...
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into ...
Of the 8000 rare disease in the world, at least four were found in Indonesia, namely Mukopolisakaridosis (MPS) type II, ...
- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a phase III, ...
- On December 20th, a decree from the President of France was published in Le Journal Officiel* appointing Denis DELVAL ...
- PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group ...
- LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of ...
- Two studies presented at World Diabetes Congress 2011 provide further evidence of the ...
- - Findings from Two-Year Pivotal Phase III TEMSO Trial ...
- - First Randomized Controlled Trial to Show That Basal Plus ...
--- Nurses Worldwide are Encouraged to Enter an Exciting Recognition Program Which Showcases Their Creativity and Their ...